Chondroblastoma: Is intralesional curettage with the use of adjuvants a sufficient way of therapy?

BACKGROUND: Chondroblastoma is a rare benign cartilaginous bone tumor that represents 1–2% of all primary bone tumors. It is characterized by aggressive growth, possible recurrence after surgical treatment and, in rare cases, metastasis. Surgical management is the primary treatment and includes intr...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Bone Oncol
Hlavní autoři: Deventer, Niklas, Deventer, Nils, Gosheger, Georg, de Vaal, Marieke, Budny, Tymoteusz, Laufer, Andrea, Heitkoetter, Birthe, Luebben, Timo
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2020
Témata:
Review Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7750402/
https://ncbi.nlm.nih.gov/pubmed/33364155
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbo.2020.100342
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky